Skip to content

Idexx Laboratories IDXX Business Segments

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Total Revenue by Business
CAG$4.09B+13.4%$3.95B+10.6%$3.83B+8.5%$3.7B+6.8%$3.6B+5.6%
LPD$135.67M+10.8%$131.79M+8.0%$128.86M+7.1%$123.91M+2.4%$122.45M+1.5%
Water segment revenue$206.09M+10.0%$201.15M+8.7%$195.77M+7.7%$191.64M+8.9%$187.36M+8.7%
Gross Profit by Business
CAG$2.54B+15.1%$2.45B+12.4%$2.36B+9.4%$2.28B+7.8%$2.21B+7.8%
LPD$66.75M+8.2%$64.21M+2.6%$62.38M+1.0%$61.06M-3.9%$61.69M-4.1%
Water segment revenue$143.75M+9.2%$139.29M+7.1%$138.33M+9.5%$135.02M+12.0%$131.59M+12.0%
Cost of revenue by Business
CAG$1.55B+10.7%$1.5B+7.9%$1.46B+5.8%$1.42B+3.8%$1.4B+3.0%
LPD$68.92M+13.4%$67.58M+13.6%$66.48M+18.4%$62.85M+12.6%$60.76M+10.2%
Water segment revenue$62.34M+11.8%$61.86M+12.3%$57.45M+3.2%$56.61M+6.2%$55.78M+7.9%
Total Revenue by Product
CAG Diagnostics capital - instruments$210.66M+62.3%$200.21M+51.8%$175.09M+27.7%$153.14M+9.5%$129.83M-6.3%
Rapid assay products$349.85M-2.1%$348.95M-3.0%$350.29M-2.7%$354.42M-0.1%$357.47M+2.5%
Recurring revenue$284.08M+10.8%$276.34M+10.4%$268.63M+11.0%$262.29M+13.1%$256.45M+15.2%
Reference laboratory diagnostic and consulting services$1.47B+9.7%$1.42B+6.6%$1.39B+5.0%$1.36B+3.0%$1.34B+2.8%
Systems and hardware$71.51M+14.1%$69.54M+11.7%$66.58M+8.0%$64.16M+0.9%$62.7M-2.9%
Cost of revenue by Product
Product revenue$823.51M+15.2%$804.62M+12.4%$770.03M+7.0%$739.34M+2.4%$714.84M-0.9%
Service revenue$863.64M+6.9%$839.51M+4.6%$825.25M+4.3%$813.56M+4.8%$807.76M+5.8%
Revenue, remaining performance obligation (as a percent) by Product
Customer commitment arrangements, multi-year arrangements107%+1.0pp106%0.0pp106%0.0pp106%106%
Extended warranties and post contract support151%+1.0pp151%+2.0pp151%-1.0pp150%150%
Reagent rental arrangements106%+2.0pp105%+3.0pp107%+5.0pp105%104%
Rebate and up-front considerations arrangements113%-11.0pp114%-10.0pp119%-4.0pp122%124%
Revenue by Product
CAG Diagnostics services and accessories$140.99M+7.7%$137.42M+5.4%$134.3M+3.1%$133.36M+4.9%$130.85M+3.8%
IDEXX VetLab consumables$1.56B+17.5%$1.5B+14.8%$1.44B+13.5%$1.38B+11.7%$1.33B+9.6%
Estimation of future revenues by Product
Customer commitment arrangements, multi-year arrangements$19.3B+10.9%$19.1B+15.1%$18.5B+15.6%$18B$17.4B
Extended warranties and post contract support$37M+3.6%$36.4M0.0%$35.6M-4.8%$35.7M$35.7M
Reagent rental arrangements$344.6M+25.6%$311.7M+17.6%$286.1M+13.4%$282.6M$274.3M
Total consolidated revenue by Geography
Latin America & Caribbean$93.64M+12.2%$90.41M+8.0%$86.5M+2.0%$84.45M-0.9%$83.44M-1.5%
Total Revenue by Geography
Asia Pacific$368.58M+12.9%$355.93M+10.9%$345.07M+7.8%$335.32M+5.9%$326.45M+2.9%
Canada$170.97M+11.4%$167.33M+9.4%$163.62M+8.0%$159.17M+6.0%$153.47M+1.7%
Europe, the Middle East and Africa$989.76M+22.0%$937.25M+16.2%$890.49M+13.8%$844.03M+10.8%$811.45M+9.7%
United States$2.82B+10.4%$2.75B+8.7%$2.68B+7.0%$2.61B+5.8%$2.56B+5.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How does Idexx Laboratories break its business down?
Idexx Laboratories (IDXX) reports total revenue by business across 3 parts — CAG, LPD and Water segment revenue. Each is extracted from the segment footnotes and tracked over time.
Where does Idexx Laboratories's segment data come from?
Segment breakdowns are pulled from the segment footnotes in Idexx Laboratories's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.